Management Optimization in Atopic Dermatitis - Episode 9

Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies

EP. 1: Persistent and Recurrent Atopic Dermatitis
EP. 2: Atopic Dermatitis: Current and Future Management
EP. 3: Weighing Quality of Life Improvements in Atopic Dermatitis
EP. 4: Understanding Emerging Therapies in Atopic Dermatitis
EP. 5: Atopic Dermatitis: Cost and Value
EP. 6: Measuring Outcomes in Atopic Dermatitis
EP. 7: Atopic Dermatitis: Reimbursement Challenges
EP. 8: Identifying the Appropriate Patients for Atopic Dermatitis Treatments
Now Viewing
EP. 9: Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies
EP. 10: Evidence and Outcomes in Atopic Dermatitis
EP. 11: Practical Application of Clinical Trial Measures in Atopic Dermatitis
EP. 12: Utilization Management Nuances in Atopic Dermatitis
EP. 13: Atopic Dermatitis: Evolving Role of Specialty Pharmacy
EP. 14: Specialty Pharmacy, Payer Goals in Atopic Dermatitis Management
EP. 15: The Future of Atopic Dermatitis
EP. 16: One Patient's Journey with Atopic Dermatitis
EP. 17: Impact of Atopic Dermatitis on Day-to-Day Life
EP. 18: Atopic Dermatitis: Dupilumab and Increase in Patient Quality of Life
EP. 19: Atopic Dermatitis: One Patient's Experience with Instructions Regarding Use of Dupilumab
EP. 20: Advice for Patients with Atopic Dermatitis

Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Ed Pezalla, MD, MPH, discuss determining and recognizing utilization management for long-term systemic therapies in patients with atopic dermatitis.